EGF and neuroblastoma: To determine the influence of CD activity on the proliferative potential, we calculated the doubling time (Dt) of these NB cell lines treated with EGF in the presence/absence of Pepstatin A (PstA), a specific inhibitor of CD (Figure 3B).